The 93 7267 pill is zolpidem tartrate 10mg — generic Ambien manufactured by Teva — a Schedule IV sedative-hypnotic used for short-term insomnia treatment. It carries a black box warning for complex sleep behaviors (sleepwalking, sleep-driving), is dosed lower in women and older adults, and should never be combined with alcohol or CNS depressants.
What Is the 93 7267 Pill? Zolpidem 10mg (Ambien) Identification
The 93 7267 pill is a white, oval tablet imprinted with "93" on one side and "7267" on the other. It contains zolpidem tartrate 10mg and is manufactured by Teva Pharmaceuticals — the "93" prefix was the historical identifier for Teva's US generics division. This tablet is a generic equivalent of Ambien 10mg, one of the most commonly prescribed sleep medications in the United States.
DEA SCHEDULE IV CONTROLLED SUBSTANCE — Zolpidem has accepted medical use but carries potential for abuse, physical dependence, and complex sleep-related behaviors. A valid prescription is required. Possession without a prescription or sharing with others is illegal. Dispose of unused tablets through a DEA-authorized take-back program — do not share or resell.
Drug Class: The "Z-Drugs"
Zolpidem belongs to a class of medications known as non-benzodiazepine hypnotics, commonly called "Z-drugs" — a group that also includes zaleplon (Sonata) and eszopiclone (Lunesta). Despite not being chemically classified as benzodiazepines, Z-drugs act on the same receptor system and share many of the same risks, including dependence and rebound insomnia. The "non-benzo" label does not imply they are safer than benzodiazepines in all respects.
The brand name zolpidem immediate-release tablet is Ambien. The 93 7267 Teva tablet delivers the same 10mg of zolpidem as Ambien 10mg and is considered therapeutically equivalent by the FDA.
Mechanism of Action
Zolpidem acts as a positive allosteric modulator of GABA-A receptors — the primary inhibitory neurotransmitter receptors in the central nervous system. Specifically, zolpidem binds selectively to the omega-1 (BZ1) subunit, which corresponds to GABA-A receptors containing the alpha-1 subunit. This selective binding preferentially activates receptors involved in sedation and sleep induction, with comparatively less activity at receptors mediating anxiolysis, muscle relaxation, and anticonvulsant effects — the latter being more prominent with classical benzodiazepines.
However, this selectivity is partial rather than absolute. At higher doses or in susceptible individuals, zolpidem can produce effects across the spectrum of GABA-A activation, including amnesia, muscle relaxation, and disinhibition.
What Is Zolpidem Prescribed For?
Zolpidem 10mg immediate-release is FDA-approved for the short-term treatment of insomnia characterized by difficulty falling asleep. The FDA's labeling specifies short-term use of generally 7 to 10 days; use beyond 2 to 3 weeks requires careful reevaluation of the underlying sleep disorder. Long-term use is not recommended due to the risks of dependence, tolerance, and rebound insomnia.
Sex-Based Dosing Differences
In 2013, the FDA issued a safety communication requiring lower recommended starting doses for women. Women clear zolpidem from the body more slowly than men — a pharmacokinetic difference that results in higher next-morning blood levels. This sex-based difference was identified after data showed women were more likely to have next-morning blood concentrations high enough to impair driving. Current FDA guidance recommends a lower starting dose for women, with the 10mg dose reserved for those who do not respond adequately.
Side Effects
Common side effects of zolpidem include:
- Excessive sedation and drowsiness during intended waking hours
- Dizziness and coordination difficulties
- Headache
- Nausea
- Anterograde amnesia — inability to form new memories during the period the drug is active, which can persist into the morning
BLACK BOX WARNING — COMPLEX SLEEP BEHAVIORS: In 2019, the FDA added a black box warning (the most serious warning type) for zolpidem and all Z-drugs regarding complex sleep behaviors. These include sleepwalking, sleep-driving, sleep-eating, making phone calls, and engaging in sexual activity — all while asleep and with no memory of the event afterward. These behaviors have resulted in serious injuries and deaths. Zolpidem should be discontinued immediately if a complex sleep behavior episode occurs. Do not combine with alcohol or other CNS depressants — this substantially increases the risk.
Driving Impairment Warning
Do not drive, operate heavy machinery, or engage in any activity requiring full alertness within 8 hours of taking zolpidem 10mg. Next-morning impairment — including impaired driving performance that the patient may not subjectively notice — is well documented. The FDA's 2013 guidance arose specifically from studies showing next-morning blood zolpidem levels above the threshold for driving impairment in a significant proportion of users, particularly women.
Dependence, Tolerance, and Withdrawal
Physical dependence on zolpidem can develop with regular nightly use, even within the period typically considered "short-term." Tolerance — reduced effectiveness requiring higher doses for the same effect — also develops.
Withdrawal from zolpidem after regular use can produce rebound insomnia (worsened sleep compared to pre-treatment baseline), anxiety, tremor, sweating, and in severe cases, seizures. Abrupt discontinuation after prolonged use should be avoided; tapering under medical supervision is preferred.
Misuse Potential
Zolpidem has a recognized misuse profile. At doses higher than prescribed or when taken while remaining awake rather than going immediately to sleep, zolpidem can produce euphoria, disinhibition, and hallucinations. These effects contribute to its potential for recreational misuse. Street names for zolpidem include "zombie pills" and "z-bars." The Schedule IV classification reflects this recognized abuse potential.
What to Do If You Find an Unidentified 93 7267 Pill
If you find a white oval tablet with the imprints "93" and "7267" and need to confirm its identity, use a pill identifier to verify. Because zolpidem is a Schedule IV controlled substance, possession without a valid prescription is a legal violation. Unused zolpidem should be disposed of via a DEA take-back program or a pharmacy collection site — not flushed (unless the FDA's flush list specifically includes it) and not left where it could be accessed by others.
If someone has taken zolpidem and is experiencing severe respiratory depression, cannot be awakened, or is engaging in dangerous behaviors while asleep, call 911 immediately. Zolpidem overdose — particularly when combined with alcohol or other CNS depressants — can be life-threatening.
Frequently Asked Questions
What is the 93 7267 pill?
The 93 7267 pill is a white oval tablet containing zolpidem tartrate 10mg — the generic equivalent of Ambien 10mg — manufactured by Teva Pharmaceuticals. The "93" prefix was Teva's historical US generics identifier. It is a Schedule IV controlled substance used for the short-term treatment of insomnia characterized by difficulty falling asleep.
Is zolpidem the same as Ambien?
Yes. Zolpidem is the active ingredient in Ambien, and the 93 7267 tablet is considered therapeutically equivalent to Ambien 10mg by the FDA. Generic zolpidem tablets like the 93 7267 undergo bioequivalence testing to demonstrate they deliver the same drug levels in the bloodstream as the brand-name product, though inactive ingredients may differ.
Can zolpidem cause sleepwalking and other dangerous sleep behaviors?
Yes. In 2019, the FDA added a black box warning — its most serious — to zolpidem and all non-benzodiazepine hypnotics (Z-drugs) for complex sleep behaviors. These include sleepwalking, sleep-driving, sleep-eating, and engaging in activities with no memory of them afterward. These behaviors have caused serious injuries and deaths. Zolpidem should be discontinued immediately if such an episode occurs, and the risk is substantially elevated when combined with alcohol or other CNS depressants.
Why is zolpidem dangerous to combine with alcohol?
Both alcohol and zolpidem depress the central nervous system. Combining them produces additive or synergistic CNS depression that can suppress breathing to a dangerous or fatal degree. Alcohol also impairs the liver's ability to metabolize zolpidem, raising blood levels higher than expected. The FDA's labeling explicitly contraindicates this combination, and zolpidem's black box warning includes a specific prohibition against use with alcohol.
Verify this imprint using our pill identification database
Identify 93 7267 Pill